Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market To Reach Value Of About $3 Billion In 2025

Check out TBRC’s sale today for

The vascular endothelial growth factor inhibitor market consists of sales of vascular endothelial growth factor inhibitor biosimilars. Vascular endothelial growth factor (VEGF)/vascular endothelial growth factor (VEGFR) inhibitors are agents that inhibit VEGF and VEGFR activity. Vascular endothelial growth factor is an essential growth factor that promotes the growth of new blood vessels.

Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Size And Drivers:

The global vascular endothelial growth factor inhibitor market is expected to grow from $0.29 billion in 2020 to $0.37 billion in 2021 at a compound annual growth rate (CAGR) of 27.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The vascular endothelial growth factor inhibitor market is expected to reach $3.34 billion in 2025 at a CAGR of 73%. The growing prevalence of cancer and macular degeneration disease is expected to drive the VEGF inhibitor market.

Request For A Sample For The Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3437&type=smp

Trends In The Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market

Key players operating in the industry are undergoing various collaborations and partnerships to expand their product portfolio by developing new products. For instance, in August 2018, Momenta Pharmaceuticals, Inc., a US-based biotechnology company, and Mylan N.V., a pharmaceutical company based in the US, entered into a partnership for the development of M710, a proposed biosimilar to EYLEA (aflibercept) injection. EYLEA is a vascular endothelial growth factor inhibitor indicated for the treatment of various diseases including neovascular (wet) age-related macular degeneration, diabetic retinopathy and diabetic macular edema, and macular edema following retinal vein occlusion. Furthermore, in January 2020, Exonate, a biotechnology company, collaborated with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson for the development of a new eye drop for the treatment of retinal vascular diseases. Exonate developed small molecules that inhibit the production of pro-angiogenic VEGF through the selective inhibition of serine/threonine-protein kinase (SRPK1)-mediated VEGF splicing.

Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Segments:
The global vascular endothelial growth factor inhibitor market is further segmented –
By Drugs Type: Avastin, Tecentriq, Cometriq, Eylea, Others
By Route Of Administration: Oral, Intravenous
By Application: Oncology, Ophthalmology, Others
By Geography: The global vascular endothelial growth factor inhibitor market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

Read More On The Report For The Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market At:

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides vascular endothelial growth factor (VEGF) inhibitor market overviews, analyzes and forecasts market size and growth for the global vascular endothelial growth factor (VEGF) inhibitor market, vascular endothelial growth factor (VEGF) inhibitor market share, vascular endothelial growth factor (VEGF) inhibitor market players, vascular endothelial growth factor (VEGF) inhibitor market segments and geographies, vascular endothelial growth factor (VEGF) inhibitor market’s leading competitors’ revenues, profiles and market shares. The vascular endothelial growth factor (VEGF) inhibitor market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.